Literature DB >> 7706016

The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States.

B R Luce, R E Brown.   

Abstract

A case study design was used to determine the reliance on technology assessment of decisionmakers in hospitals, health maintenance organizations (HMOs), and third-party payers. Thirty different organizations were contacted and semistructured interviews conducted. The study found that hospitals, HMOs, and insurers are conducting technology assessments, but the form and sophistication of these analyses range widely. Hospitals are particularly focused on traditional financial analyses ("prudent purchasing") with the exception of pharmacy committees, which generally conduct more sophisticated socio-economic analyses. HMOs and insurers conduct outcome assessments for coverage of expensive or controversial technologies but exclude economics. Technology assessment will become increasingly important in resource allocation decision making and it is in the interest of technology providers to foster better information, a more comprehensive assessment process, and a more efficient assessment system.

Mesh:

Year:  1995        PMID: 7706016     DOI: 10.1017/s0266462300005274

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  9 in total

1.  Linking health technology assessment to practice. Interview by Abi Berger.

Authors:  R Rosen; J Gabbay
Journal:  BMJ       Date:  1999-11-13

Review 2.  The effect of managed care on prescription drug costs and benefits.

Authors:  A Lyles; F B Palumbo
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

3.  Hospital-based comparative effectiveness centers: translating research into practice to improve the quality, safety and value of patient care.

Authors:  Craig A Umscheid; Kendal Williams; Patrick J Brennan
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

Review 4.  Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.

Authors:  Marieke E van Velden; Johan L Severens; Annoesjka Novak
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  'Medicine's next goldmine?' The implications of new genetic health technologies for the health service.

Authors:  Michael Calnan; David Wainwright; Peter Glasner; Ruth Newbury-Ecob; Ewan Ferlie
Journal:  Med Health Care Philos       Date:  2006

6.  Controlling the introduction of new and emerging medical technologies: can we meet the challenge?

Authors:  R Rosen; N Mays
Journal:  J R Soc Med       Date:  1998-01       Impact factor: 5.344

7.  Economic evaluation of nimesulide versus diclofenac in the treatment of osteoarthritis in Greece.

Authors:  L Liaropoulos; M Spinthouri; T Ignatiades; G Ifandi; F Katostaras; E Diamantopoulos
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 8.  Effects and repercussions of local/hospital-based health technology assessment (HTA): a systematic review.

Authors:  Marie-Pierre Gagnon; Marie Desmartis; Thomas Poder; William Witteman
Journal:  Syst Rev       Date:  2014-10-28

Review 9.  The clinical case for proton beam therapy.

Authors:  Robert L Foote; Scott L Stafford; Ivy A Petersen; Jose S Pulido; Michelle J Clarke; Steven E Schild; Yolanda I Garces; Kenneth R Olivier; Robert C Miller; Michael G Haddock; Elizabeth Yan; Nadia N Laack; Carola A S Arndt; Steven J Buskirk; Vickie L Miller; Christopher R Brent; Jon J Kruse; Gary A Ezzell; Michael G Herman; Leonard L Gunderson; Charles Erlichman; Robert B Diasio
Journal:  Radiat Oncol       Date:  2012-10-22       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.